Furthermore, TLR4 expression seems to be associated with the development/maintenance of hypertension because treatment of SHRs with an anti-TLR4 antibody for 2 weeks reduced blood pressure, as previously described [32]. Here, TLR4 is linked to hypertensive disorder.